Drug Label Information | Brands:
Brands of Dapsone in Kenya
- Leprosy:Oral: 100 mg daily, in combination with other antileprosy agents; duration of therapy is variable
- Dermatitis herpetiformis:Oral: Start at 50 mg daily, increase to 300 mg daily, or higher to achieve full control, reduce dosage to minimum level as soon as possible
- Bullous systemic lupus erythematosus (unlabeled use):Oral: 100 mg once daily with or without prednisone (Fabbri, 2003)
- Aphthous ulcers, severe (unlabeled use): Oral:-Initial: 25 mg daily for 3 days; increase dose inincrements of 25 mg daily every 3 days up to 100 mg daily for 3 days, then increase by 25 mg daily every 7 days up to 150 mg daily. Administer in 2 divided doses (75 mg dose is administered in 3 divided doses). -Maintenance: 100-150 mg daily in 2 divided doses with or without concomitant colchicine (Rogers, 1982; Lynde 2009)
Absolute contraindications to the use of dapsone are prior hypersensitivity to dapsone or its derivatives including agranulocytosis and hypersensitivity syndrome
Some products that may interact with this drug are: folic acid antagonists (such as pyrimethamine), nitrofurantoin, primaquine.
Other medications can affect the removal of dapsone from your body, which may affect how dapsone works. An example is saquinavir, among others.
Common side effects of dapsone include:
- loss of appetite,
- blurred vision,
- ringing in the ears,
NB: Never take a Drug without seeing a doctor